Bridgewater Associates’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,353
| Closed | -$217K | – | 745 |
|
2024
Q4 | $217K | Sell |
2,353
-5,730
| -71% | -$528K | ﹤0.01% | 670 |
|
2024
Q3 | $751K | Sell |
8,083
-15,389
| -66% | -$1.43M | ﹤0.01% | 637 |
|
2024
Q2 | $1.93M | Buy |
23,472
+5,019
| +27% | +$413K | 0.01% | 540 |
|
2024
Q1 | $1.22M | Sell |
18,453
-2,948
| -14% | -$196K | 0.01% | 553 |
|
2023
Q4 | $1.21M | Sell |
21,401
-2,235
| -9% | -$127K | 0.01% | 608 |
|
2023
Q3 | $1.29M | Buy |
23,636
+1,968
| +9% | +$107K | 0.01% | 570 |
|
2023
Q2 | $1.46M | Sell |
21,668
-2,279
| -10% | -$153K | 0.01% | 517 |
|
2023
Q1 | $1.23M | Buy |
23,947
+975
| +4% | +$50.2K | 0.01% | 535 |
|
2022
Q4 | $1.06M | Sell |
22,972
-7,863
| -26% | -$362K | 0.01% | 637 |
|
2022
Q3 | $1.56M | Buy |
30,835
+94
| +0.3% | +$4.77K | 0.01% | 610 |
|
2022
Q2 | $1.4M | Buy |
30,741
+2,803
| +10% | +$128K | 0.01% | 748 |
|
2022
Q1 | $1.3M | Buy |
27,938
+6,584
| +31% | +$306K | 0.01% | 765 |
|
2021
Q4 | $1.07M | Buy |
21,354
+2,402
| +13% | +$121K | 0.01% | 560 |
|
2021
Q3 | $1.01M | Buy |
+18,952
| New | +$1.01M | 0.01% | 518 |
|